154 results
Page 7 of 8
8-K
EX-10.4
25ff4onjp
9 May 13
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.2
tiorp6q5fpaiyev rwfc
9 May 13
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
uey9 dfbelgq946xfu
9 Apr 13
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.2
rz9gj15j97v61f3t9g
26 Mar 13
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
5bkuu6eqoa
26 Mar 13
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
ubdjop oqfe
7 Jan 13
Orgenesis Announces Management Changes
12:00am
8-K
EX-10.3
b5p q4azekm2w
10 Dec 12
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
8kou0dl9sqeknq2 y9
27 Nov 12
Orgenesis Appoints Leading Diabetes Expert, Camillo Ricordi, M.D., to Scientific Advisory Board
12:00am
8-K
EX-10.1
f1btu a4n
9 Nov 12
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
euh15lpy zd
9 Oct 12
Termination of a Material Definitive Agreement
12:00am
8-K
EX-10.2
timyi69 m5
3 Aug 12
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
pgn8uldv zcovv8wn
3 Aug 12
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
wjb5v6
31 May 12
Orgenesis Inc. Appoints Ex FDA Officer and Diabetes Authority to Scientific Advisory Board
12:00am
8-K
EX-10.1
28gf5c4mpd60kmbblnt
31 May 12
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.2
hay2nmsr8l6jpnv
2 May 12
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
sxcbp jb8q
2 May 12
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
buk45z 4c578q
25 Apr 12
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
j71716
23 Apr 12
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
dhcppyeq153 ef
13 Apr 12
Orgenesis Inc. Enters Into Agreement to Commence Advanced Studies for Proposed Diabetes Treatment
12:00am
8-K
EX-10.1
iamqs6bc680pkn
5 Apr 12
Entry into a Material Definitive Agreement
12:00am